Kazakhstan vs Slovenia: Previously treated cases tested for RR-/MDR-TB
Kazakhstan
100.0%
in 2024
Slovenia
100.0%
in 2024
Kazakhstan rank
1st
Slovenia rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Kazakhstan
- Slovenia
How they compare
Kazakhstan currently reports 100.0% against 100.0% in Slovenia, a difference of 0.0%.
The two have swapped places 6 times across 19 shared years of data; in 2006 it was Slovenia ahead.
Kazakhstan ranks 1st and Slovenia ranks 1st of 180 countries.
Across the 3 decades both report, Kazakhstan averaged higher in 1 and Slovenia in 2.
Head to head by decade
| Decade | Kazakhstan | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.2% | 81.5% | 31.2% | Slovenia |
| 2010s | 87.4% | 88.4% | 1.0% | Slovenia |
| 2020s | 100.0% | 96.6% | 3.4% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Kazakhstan or Slovenia?
- Kazakhstan, at 100.0% against 100.0% in Slovenia as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Kazakhstan and Slovenia?
- 0.0%, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Slovenia?
- 19 years are reported by both, from 2006 to 2024.
- How do Kazakhstan and Slovenia rank globally for previously treated cases tested for rr-/mdr-tb?
- Kazakhstan ranks 1st and Slovenia ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.